Veterinary Medicines

Versican Plus BbPI IN nasal drops, lyophilisate and solvent for suspension for dogs

Authorised
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Bordetella bronchiseptica, strain MSLB 3096, Live
Download as PDF

Product identification

Medicine name:
Versican Plus BbPi IN gouttes nasales, lyophilisat et solvant pour suspension pour chiens
Versican Plus BbPI IN nasal drops, lyophilisate and solvent for suspension for dogs
Active substance:
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Bordetella bronchiseptica, strain MSLB 3096, Live
Target species:
  • Dog
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    3.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Bordetella bronchiseptica, strain MSLB 3096, Live
    8.00
    log10 colony forming unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AF01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • (ID2): 1 Box with (10 Vial (Glass) with 1 Dose and 10 Vial (Glass) with 0.5 millilitre(s)) (10.0 Dose, 5.0 millilitre(s))
  • (ID1): 1 Box with (5 Vial (Glass) with 1 Dose and 5 Vial (Glass) with 0.5 millilitre(s)) (5.0 Dose, 2.5 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 087/20/04/1802
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0288/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/03/2023
Download

Combined File of all Documents

English (PDF)
Published on: 14/11/2025
Download

2613944-paren-20251101.pdf

English (PDF)
Published on: 27/11/2025
Download